HR 6288 · 118th Congress · Health

Data for Pediatric Brain Cancer Act of 2023

Introduced 2023-11-08· Sponsored by Rep. Bera, Ami [D-CA-6]· House

Bill Progress

Introduced
2
Committee
3
House Vote
4
Senate
5
Enacted
Latest: Referred to the Subcommittee on Health.(2023-11-10)

Plain Language Summary

[AI summary unavailable — showing source text] [Congressional Bills 118th Congress] [From the U.S. Government Publishing Office] [H.R. 6288 Introduced in House (IH)] <DOC> 118th CONGRESS 1st Session H. R. 6288 To amend the Federal Food, Drug, and Cosmetic Act to provide for a Pediatric Brain Tumor Real-World Data Registry Program, and for other purposes. _______________________________________________________________________ IN THE HOUSE OF REPRESENTATIVES November 8, 2023 Mr. Bera (for himself and Mr. Kelly of Pennsylvania) introduced the following bill; which was referred to the Committee on Energy and Commerce _______________________________________________________________________ A BILL To amend the Federal Food, Drug, and Cosmetic Act to provide for a Pediatric Brain Tumor Real-World Data Registry Program, and for other purposes. Be it enacted by the Senate and House of Representatives of the United States of America in Congress assembled, SECTION 1. SHORT TITLE. This Act may be cited as the ``Data for Pediatric Brain Cancer Act of 2023''. SEC. 2. FINDINGS. Congress finds the following: (1) Randomized clinical trials require the use of control groups to serve as the baseline for determining the effectiveness of a stu…

Summarized by Claude AI · Non-partisan · For informational purposes only

Cosponsors (2)

1 Democrat1 Republican